Skip to content

Gyre Therapeutics, Inc. GYRE All Other Segments — Allocated Share Based Compensation Expense

Other segment segments

Gyre Pharmaceuticals
$1.71M+2,096%
Gyre
$870K+103%

Similar metrics at other companies

Nektar Therapeutics logo
NKTRAll Other Segments — Allocated Share Based Compensation Expense
$3.36M-13.9%
Sarepta Therapeutics, Inc. logo
SRPTAll Other Segments — Stock-Based Comp
$29.4M-29.0%
Rush Enterprises logo
RUSHBAll Other Segments — Allocated Expenses
$2.12M+432%
HCI Group logo
HCICorporate And Other — Allocated Share Based Compensation Expense
$1.94M+9.2%
Amplitude, Inc. logo
AMPLAll Other Segments — Employee Benefits And Share Based Compensation
$20.5M-5.9%
Vertex, Inc. logo
VERXService Other — Allocated Share Based Compensation Expense
$1.67M-1.5%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s all other segments — allocated share based compensation expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s all other segments — allocated share based compensation expense?
Gyre Therapeutics, Inc. (GYRE) reported all other segments — allocated share based compensation expense of $0 in Q1 2026.
What does all other segments — allocated share based compensation expense mean?
This metric represents the portion of total share-based compensation expenses specifically allocated to the 'All Other Segments' business unit. It reflects the non-cash cost of equity-based incentives provided to employees or contractors associated with these operations. Tracking this helps assess the true operational cost structure and management incentive alignment within the segment.